ExpreS2ion Biotechnologies Employee Directory
Biotechnology ResearchHovedstaden, Denmark11-50 Employees
ExpreS2ion Biotechnologies is a clinical-stage biotechnology company based in Hørsholm, Capital Region of Denmark, founded in 2010. It specializes in developing vaccines and immunotherapies, supported by a proprietary expression platform designed to enable fast production of complex proteins for innovative vaccines, therapies, and diagnostics. Its development pipeline includes a breast cancer vaccine candidate in clinical development and a Nipah virus vaccine program in preclinical stages, with additional malaria vaccines in collaboration with academic partners and newer influenza vaccine candidates. The company operates through collaborations with a 34%-owned associated company and maintains a fully owned Danish subsidiary that is part of ExpreS2ion Biotech Holding AB, which is listed on Nasdaq First North Growth Market. It engages with research institutions and industry partners to advance its vaccine and immunotherapy programs.
1-888-653-2347 
support@leadiq.com 
